Key result
The PROMITAR platform enabled programmable miRNA-based translation control in circular RNAs, achieving up to 89-fold differences in targeted cytotoxicity between cancer and healthy cell lines.
Why the study?
Translational circular RNAs were developed as promising alternatives to linear messenger RNAs, but still lack straightforward and programmable translation control strategies.
Answers are grounded in this paper and cite their sources.
The PROMITAR platform enables programmable, miRNA-responsive translational control in circular RNAs, providing a novel synthetic biology tool for targeted cancer cell elimination.
Artificial RNA translation modulation usually relies on multiple components, such as RNA binding proteins (RBPs) or microRNAs (miRNAs) for off-switches and double-inverter cascades for on-switches. Recently, translational circular RNAs (circRNAs) were developed as promising alternatives for linear messenger RNAs (mRNAs). However, circRNAs still lack straightforward and programmable translation control strategies. Here, we rationally design a programmable miRNA-responsive internal ribosome entry site (IRES) translation activation and repression (PROMITAR) platform capable of implementing miRNA-based translation upregulation and downregulation in a single RNA construct. Based on the PROMITAR platform, we construct logic gates and cell-type classifier circRNAs and successfully identify desired mammalian cell types. We also demonstrate the potential therapeutic application of our platform for targeted cancer cell killing by encoding a cytotoxic protein in our engineered circRNAs. We expect our platform to expand the toolbox for RNA synthetic biology and provide an approach for potential biomedical applications in the future.
No takes yet. Share an insight, caveat, or question.
Ning et al. (2023) studied this question. PROMITAR platform (miRNA-responsive IRES translation switches in circRNAs) vs. Native IRES or control constructs was evaluated on Translation efficiency and cell-type specific cytotoxicity (LDH release). The PROMITAR platform enabled programmable miRNA-based translation control in circular RNAs, achieving up to 89-fold differences in targeted cytotoxicity between cancer and healthy cell lines.
Synapse has enriched 10 related papers. Consider them for comparative context: